Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACTT: Gemcitabine and S-1 in Pancreatic Cancer
NCT00429858Phase 2Terminated
- Start
- Jan 2007
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, tegafur in pancreatic adenocarcinoma (PDAC). Started Jan 2007; status: terminated.
02
Drugs
gemcitabinetegafur
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00429858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429858.